Chief operating officer, Scholar Rock
Appears in 1 story
Last updated Sep 16, 2026
As of September 2026: Running the commercial launch of Isembyld
Patients with spinal muscular atrophy (SMA) have had drugs that keep motor neurons alive for a decade. None stopped the muscle wasting that defines advanced disease. On September 11, 2026, the FDA approved the first treatment built to do that.
Updated Sep 16
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
